Rabbit plasma metabolomic analysis of Nitroproston®: a multi target natural prostaglandin based-drug
暂无分享,去创建一个
I. I. Lyubimov | V. Bezuglov | I. Serkov | N. Moskaleva | Alex Brito | Ksenia M. Shestakova | S. Appolonova | N. Mesonzhnik | Ksenia O. Kurynina | Natalia M. Grestskaya
[1] I. I. Lyubimov,et al. LC-MS/MS Identification and Structural Characterization of Main Biodegradation Products of Nitroproston - A Novel Prostaglandin-based Pharmaceutical Compound. , 2018, Drug Metabolism Letters.
[2] Ó. Pozo,et al. Targeting human urinary metabolome by LC-MS/MS: a review. , 2018, Bioanalysis.
[3] Bofei Zhang,et al. RaMP: A Comprehensive Relational Database of Metabolomics Pathways for Pathway Enrichment Analysis of Genes and Metabolites , 2018, Metabolites.
[4] D. Fitzgerald,et al. Question 1: Why do children still die from asthma? , 2018, Paediatric respiratory reviews.
[5] G. Siuzdak,et al. METLIN: A Technology Platform for Identifying Knowns and Unknowns. , 2018, Analytical chemistry.
[6] S. Jee,et al. Elevated Metabolites of Steroidogenesis and Amino Acid Metabolism in Preadolescent Female Children With High Urinary Bisphenol A Levels: A High-Resolution Metabolomics Study , 2017, Toxicological sciences : an official journal of the Society of Toxicology.
[7] X. Nie,et al. Metabolic profiling of asthma in mice and the interventional effects of SPA using liquid chromatography and Q-TOF mass spectrometry. , 2017, Molecular bioSystems.
[8] Hui Wang,et al. UHPLC-Q-TOF/MS based plasma metabolomics reveals the metabolic perturbations by manganese exposure in rat models. , 2017, Metallomics : integrated biometal science.
[9] T. Asano,et al. Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic Steatohepatitis , 2016, Mediators of inflammation.
[10] Yonggui Pan,et al. Pathway Analysis and Metabolites Identification by Metabolomics of Etiolation Substrate from Fresh-Cut Chinese Water Chestnut (Eleocharis tuberosa) , 2016, Molecules.
[11] Fengguo Xu,et al. Time-resolved metabolomics analysis of individual differences during the early stage of lipopolysaccharide-treated rats , 2016, Scientific Reports.
[12] Massimo Broggini,et al. Comparative metabolomics profiling of isogenic KRAS wild type and mutant NSCLC cells in vitro and in vivo , 2016, Scientific Reports.
[13] W. Yao,et al. Metabolic alterations in the sera of Chinese patients with mild persistent asthma: a GC-MS-based metabolomics analysis , 2015, Acta Pharmacologica Sinica.
[14] J. McDunn,et al. Metabolomic Endotype of Asthma , 2015, The Journal of Immunology.
[15] Huwei Liu,et al. Metabolomics Approach Reveals Integrated Metabolic Network Associated with Serotonin Deficiency , 2015, Scientific Reports.
[16] Yue-qin Tang,et al. A metabolomic and pharmacokinetic study on the mechanism underlying the lipid-lowering effect of orally administered berberine. , 2015, Molecular bioSystems.
[17] R. Pawankar,et al. Allergic diseases and asthma: a global public health concern and a call to action , 2014, The World Allergy Organization journal.
[18] V·V·贝祖格鲁夫,et al. Broncholytic drug on the basis of prostaglandin , 2013 .
[19] Frank J. Gonzalez,et al. LC-MS-based metabolomics in profiling of drug metabolism and bioactivation , 2012 .
[20] H. Ressom,et al. LC-MS-based metabolomics. , 2012, Molecular bioSystems.
[21] M. Belvisi,et al. Prostaglandin E2 mediates cough via the EP3 receptor: implications for future disease therapy. , 2009, American journal of respiratory and critical care medicine.
[22] G. Saidel,et al. Role of the malate-aspartate shuttle on the metabolic response to myocardial ischemia. , 2008, Journal of theoretical biology.
[23] P. Barnes. How corticosteroids control inflammation: Quintiles Prize Lecture 2005 , 2006, British journal of pharmacology.
[24] S. Bornstein,et al. The rapid release of corticosterone from the adrenal induced by ACTH is mediated by nitric oxide acting by prostaglandin E2 , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[25] D. Kang,et al. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. , 2005, Seminars in nephrology.
[26] A. Fernie,et al. Metabolite profiling: from diagnostics to systems biology , 2004, Nature Reviews Molecular Cell Biology.
[27] H. Jabbour,et al. Expression, localization, and signaling of PGE(2) and EP2/EP4 receptors in human nonpregnant endometrium across the menstrual cycle. , 2001, The Journal of clinical endocrinology and metabolism.
[28] J. Oates,et al. EP(2) receptor mediates bronchodilation by PGE(2) in mice. , 2000, Journal of applied physiology.
[29] M. Marletta,et al. Guanylate cyclase and the .NO/cGMP signaling pathway. , 1999, Biochimica et biophysica acta.
[30] L. Walch,et al. Prostanoid receptors involved in the relaxation of human bronchial preparations , 1999, British journal of pharmacology.
[31] W. J. Visek,et al. Ammonia metabolism, urea cycle capacity and their biochemical assessment. , 2009, Nutrition reviews.
[32] A. Lehninger,et al. Occurrence of the malate-aspartate shuttle in various tumor types. , 1976, Cancer research.